Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, Guangzhou Baiyunshan Chen Liji Pharmaceutical Co., Ltd. (“Chen Liji Pharmaceutical Factory”), a subsidiary of the company, received the approval and issuance of the “Drug Clinical Trial Approval Notice” from the State Drug Administration on the treatment of the new functions of the Soojianjian Waist Pill. It was agreed that this product will carry out clinical trials for lumbar disc herniation, hepatic and renal insufficiency, and rheumatic stasis.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.